Androgen receptor: a potential therapeutic target for glioblastoma-Reference-Cited by-同舟云学术

Androgen receptor: a potential therapeutic target for glioblastoma

Published:2018-04-13 Issue:28 Volume:9 Page:19980-19993
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zalcman Nomi¹²,Canello Tamar¹²,Ovadia Haim²,Charbit Hanna¹²,Zelikovitch Bracha¹²,Mordechai Anat¹³,Fellig Yakov⁴,Rabani Stav⁵,Shahar Tal⁵⁶,Lossos Alexander¹²³,Lavon Iris¹²

Affiliation:

1. Leslie and Michael Gaffin Center for Neuro-Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

2. Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

3. Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

4. Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

5. The Laboratory for Molecular Neuro-Oncology, Department of Neurosurgery, Tel Aviv Medical Center, Tel Aviv, Israel

6. Department of Neurosurgery, Shaare Zedek Medical Center, Jerusalem, Israel

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics;Steroids;2024-10

2. Sex difference in human diseases: mechanistic insights and clinical implications;Signal Transduction and Targeted Therapy;2024-09-10

3. Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy;Toxicology and Applied Pharmacology;2024-09

4. Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levels;Cancer Letters;2024-08

5. A novel L-shaped ortho-quinone analog suppresses glioblastoma progression by targeting acceleration of AR degradation and regulating PI3K/AKT pathway;Biochemical Pharmacology;2024-08